CLINICAL_TRIALS
trial_result
· 2025-02-27
Clinical Trial Update: Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux Disease [Phase 4]
Summary
A Phase 4 trial comparing vonoprazan with dexlansoprazole for gastroesophageal reflux disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ayman Magd Eldin Mohammad Sadek | Conditions: Vonoprazan, Proton Pump Inhibitor | Phase 4 | Status: COMPLETED